BIO-TECHNE Corp SEC filings TECH
BIO-TECHNE Corp has 1,001 filings in SEC EDGAR's recent list, going back to Apr 29, 2008. Its latest annual report, Form 10-K, was filed on Aug 24, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 6, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Sep 14, 2026 | — |
| DEFA14A | Additional proxy material | Sep 9, 2026 | — |
| DEFA14A | Additional proxy material | Sep 2, 2026 | — |
| DEFA14A | Additional proxy material | Aug 25, 2026 | — |
| DEFM14A | Filing | Aug 20, 2026 | — |
| PREM14A | Filing | Aug 10, 2026 | Aug 10, 2026 |
| DEFA14A | Additional proxy material | Jul 9, 2026 | — |
| DEFA14A | Additional proxy material | Jun 25, 2026 | — |
| DEFA14A | Additional proxy material | Sep 19, 2025 | — |
| DEF 14A | Proxy statement | Sep 19, 2025 | Oct 30, 2025 |
| DEFA14A | Additional proxy material | Sep 12, 2024 | — |
| DEF 14A | Proxy statement | Sep 12, 2024 | Oct 24, 2024 |
| DEFA14A | Additional proxy material | Sep 13, 2023 | — |
| DEF 14A | Proxy statement | Sep 13, 2023 | Oct 26, 2023 |
| DEFA14A | Additional proxy material | Sep 14, 2022 | — |
| DEF 14A | Proxy statement | Sep 14, 2022 | Oct 27, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 1, 2022 | Oct 27, 2022 |
| DEFA14A | Additional proxy material | Sep 15, 2021 | — |
| DEF 14A | Proxy statement | Sep 14, 2021 | Oct 28, 2021 |
| DEFA14A | Additional proxy material | Sep 15, 2020 | — |
| DEF 14A | Proxy statement | Sep 15, 2020 | Oct 29, 2020 |
| DEFA14A | Additional proxy material | Sep 9, 2019 | — |
| DEF 14A | Proxy statement | Sep 9, 2019 | Oct 24, 2019 |
| DEFA14A | Additional proxy material | Sep 11, 2018 | — |
| DEF 14A | Proxy statement | Sep 11, 2018 | Oct 25, 2018 |
| DEFA14A | Additional proxy material | Sep 12, 2017 | — |
| DEF 14A | Proxy statement | Sep 12, 2017 | Oct 26, 2017 |
| DEFA14A | Additional proxy material | Sep 13, 2016 | — |
| DEF 14A | Proxy statement | Sep 13, 2016 | Oct 27, 2016 |
| DEFA14A | Additional proxy material | Sep 18, 2015 | — |
| DEF 14A | Proxy statement | Sep 18, 2015 | Oct 29, 2015 |
| DEFA14A | Additional proxy material | Sep 19, 2014 | — |
| DEF 14A | Proxy statement | Sep 19, 2014 | Oct 30, 2014 |
| PRE 14A | Preliminary proxy statement | Sep 9, 2014 | Oct 30, 2014 |
| DEFA14A | Additional proxy material | Oct 15, 2013 | — |
| DEF 14A | Proxy statement | Sep 20, 2013 | Oct 31, 2013 |
| DEF 14A | Proxy statement | Sep 14, 2012 | Oct 25, 2012 |
| PRE 14A | Preliminary proxy statement | Sep 4, 2012 | Oct 25, 2012 |
| DEF 14A | Proxy statement | Sep 16, 2011 | Oct 27, 2011 |
| DEF 14A | Proxy statement | Sep 17, 2010 | Oct 28, 2010 |
| DEF 14A | Proxy statement | Sep 22, 2009 | Oct 29, 2009 |
| DEF 14A | Proxy statement | Sep 18, 2008 | Sep 18, 2008 |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECH (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- MN
- Headquarters
- Minneapolis, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 842023
- Former names
- TECHNE CORP /MN/ (until Oct 28, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.